Preparation for International Cooperation on Cosmetics Regulation 14th Annual Meeting; Public Meeting; Cancellation, 17088 [2020-06280]

Download as PDF 17088 Federal Register / Vol. 85, No. 59 / Thursday, March 26, 2020 / Notices Authority The authority for these orders is Sections 362 and 365 of the Public Health Service Act (42 U.S.C. 265, 268). Dated: March 20, 2020. Robert K. McGowan Chief of Staff, Centers for Disease Control and Prevention. [FR Doc. 2020–06327 Filed 3–23–20; 3:15 pm] BILLING CODE 4163–18–C DEPARTMENT OF HEALTH AND HUMAN SERVICES Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention lotter on DSKBCFDHB2PROD with NOTICES Notice of Closed Meeting [FR Doc. 2020–06272 Filed 3–25–20; 8:45 am] Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— EH–20–001, Environmental Health Specialists Network (EHS-Net)— Practice based research to improve food safety. Date: June 3–4, 2020. Time: 8:30 a.m. to 5:00 p.m., EDT. Place: Videoconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Mikel Walters, Ph.D., Scientific Review VerDate Sep<11>2014 17:20 Mar 25, 2020 Official, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone (404) 639–0913, MWalters@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Jkt 250001 BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2020–N–0001] Preparation for International Cooperation on Cosmetics Regulation 14th Annual Meeting; Public Meeting; Cancellation AGENCY: Food and Drug Administration, HHS. Notice of cancellation of public meeting. ACTION: SUMMARY: The Food and Drug Administration (FDA or we) is announcing the cancellation of following public meeting entitled ‘‘International Cooperation on Cosmetics Regulation (ICCR)— Preparation for ICCR–14 Meeting.’’ The purpose of the public meeting was to invite public input on various topics pertaining to the regulation of cosmetics. DATES: The public meeting was to be held on April 14, 2020, from 2 p.m. to 4 p.m. ADDRESSES: The public meeting was to be held at the Food and Drug Administration, Center for Food Safety PO 00000 Frm 00048 Fmt 4703 Sfmt 9990 and Applied Nutrition, 5001 Campus Dr., Wiley Auditorium (first floor), College Park, MD 20740. FOR FURTHER INFORMATION CONTACT: Deborah Smegal, Office of Cosmetics and Colors, Food and Drug Administration, 5001 Campus Dr. (HFS– 100), College Park, MD 20740, 240–402– 1818, Deborah.Smegal@fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background FDA, like other government agencies, is taking the necessary steps to ensure the Agency is prepared to continue our vital public health mission in the event that our day-to-day operations are impacted by the COVID–19 public health emergency. Therefore, we are canceling or postponing all nonessential meetings through the month of April. We will reassess on an ongoing basis for future months. Accordingly, the FDA public meeting entitled, ‘‘International Cooperation on Cosmetics Regulation (ICCR)— Preparation for ICCR—14 Meeting’’ announced in the Federal Register of March 3, 2020 (85 FR 12569), is canceled. Additionally, we will be closing the docket to public comments, since the purpose of the docket was to obtain information for the FDA public meeting and to help FDA prepare for the ICCR–14 meeting. Thus, because we are canceling the FDA public meeting, public comments are no longer necessary. As of March 20, 2020, the status of the ICCR–14 meeting itself remains to be determined. Please contact Deborah Smegal in FDA’s Office of Cosmetics and Colors (See FOR FURTHER INFORMATION CONTACT) with questions. Dated: March 20, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020–06280 Filed 3–25–20; 8:45 am] BILLING CODE 4164–01–P E:\FR\FM\26MRN1.SGM 26MRN1 EN26MR20.052</GPH> BILLING CODE 4163–18–C

Agencies

[Federal Register Volume 85, Number 59 (Thursday, March 26, 2020)]
[Notices]
[Page 17088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06280]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2020-N-0001]


Preparation for International Cooperation on Cosmetics Regulation 
14th Annual Meeting; Public Meeting; Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of cancellation of public meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is announcing the 
cancellation of following public meeting entitled ``International 
Cooperation on Cosmetics Regulation (ICCR)--Preparation for ICCR-14 
Meeting.'' The purpose of the public meeting was to invite public input 
on various topics pertaining to the regulation of cosmetics.

DATES: The public meeting was to be held on April 14, 2020, from 2 p.m. 
to 4 p.m.

ADDRESSES: The public meeting was to be held at the Food and Drug 
Administration, Center for Food Safety and Applied Nutrition, 5001 
Campus Dr., Wiley Auditorium (first floor), College Park, MD 20740.

FOR FURTHER INFORMATION CONTACT: Deborah Smegal, Office of Cosmetics 
and Colors, Food and Drug Administration, 5001 Campus Dr. (HFS-100), 
College Park, MD 20740, 240-402-1818, [email protected].

SUPPLEMENTARY INFORMATION: 

I. Background

    FDA, like other government agencies, is taking the necessary steps 
to ensure the Agency is prepared to continue our vital public health 
mission in the event that our day-to-day operations are impacted by the 
COVID-19 public health emergency. Therefore, we are canceling or 
postponing all non-essential meetings through the month of April. We 
will reassess on an ongoing basis for future months.
    Accordingly, the FDA public meeting entitled, ``International 
Cooperation on Cosmetics Regulation (ICCR)--Preparation for ICCR--14 
Meeting'' announced in the Federal Register of March 3, 2020 (85 FR 
12569), is canceled. Additionally, we will be closing the docket to 
public comments, since the purpose of the docket was to obtain 
information for the FDA public meeting and to help FDA prepare for the 
ICCR-14 meeting. Thus, because we are canceling the FDA public meeting, 
public comments are no longer necessary.
    As of March 20, 2020, the status of the ICCR-14 meeting itself 
remains to be determined.
    Please contact Deborah Smegal in FDA's Office of Cosmetics and 
Colors (See FOR FURTHER INFORMATION CONTACT) with questions.

    Dated: March 20, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-06280 Filed 3-25-20; 8:45 am]
 BILLING CODE 4164-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.